list of glp-1 agonists current and its analogs [36-39] Evolution of GLP‐1 Receptor Agonists

The primary indication for therapy is paramountpatients using these medications for type 2 diabetes management typically require long-term treatment as part of comprehensive disease management, whereas those using GLP-1 agents solely for weight management may have more flexibility depending on their response and circumstances

The FDA approved sitagliptin, the first DPP-4i on the market, in 2006 and shortly after, numerous additional DPP-4i received market clearance

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study

doi: 10.1055/s-0029-1215269 12 FolliFGuardado MendozaR

Some people notice emotional benefits, while others experience little change